A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy.

Published

Journal Article

We report the case of a patient with pseudophakic cystoid macular edema whose visual acuity improved promptly with oral administration of 500 mg of acetazolamide extended-release capsules BID for two weeks. However, vision worsened again within two weeks of discontinuation of the treatment. On resumption of acetazolamide therapy for three weeks, and its slow withdrawal during the following three weeks, the macular edema eventually resolved, and vision returned to normal. Our observation provides a direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy and shows the importance of tapering the doses of this regimen.

Full Text

Duke Authors

Cited Authors

  • Tripathi, RC; Fekrat, S; Tripathi, BJ; Ernest, JT

Published Date

  • April 1991

Published In

Volume / Issue

  • 23 / 4

Start / End Page

  • 127 - 129

PubMed ID

  • 2064253

Pubmed Central ID

  • 2064253

International Standard Serial Number (ISSN)

  • 0003-4886

Language

  • eng

Conference Location

  • United States